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Impact Statement:  
− Exposure to second-hand smoke at home and in pregnancy is a major cause of disease 
among children. 
− Smoking legislation produced the adoption of voluntary smoking bans in homes, however 
second-hand smoke exposure at homes still occurs and its burden is substantial. 
− In 2017 the number of deaths and disability-adjusted life years in children attributable to 
exposure to second-hand smoke in the European Union countries were respectively 335 
and 35633. 
− Low birth weight caused by second-hand smoke exposure in pregnancy showed the 
largest burden. 










Second-hand smoke (SHS) exposure at home and fetal SHS exposure during pregnancy are a 
major cause of disease among children. The aim of this study is quantifying the burden of 
disease due to SHS exposure in children and in pregnancy in 2006-2017 for the 28 European 
Union (EU) countries. 
Methods 
Exposure to SHS was estimated using a multiple imputation procedure based on the 
Eurobarometer surveys, and SHS exposure  burden was estimated with the Comparative Risk 
Assessment method using meta-analytical relative risks. Data on deaths and disability-
adjusted life years (DALY) were collected from National statistics and from the Global 
Burden of Disease Study. 
Results 
Exposure to SHS and its attributable burden stalled in 2006-2017; in pregnant women, SHS 
exposure was 19.8% in 2006, 19.1% in 2010, 21.0% in 2017; in children it was 10.1% in 
2006, 9.6% in 2010, 12.1% in 2017. In 2017, 35,633 DALYs among children were 
attributable to SHS exposure in the EU, mainly due to low birth weight. 
Conclusions 
Comprehensive smoking bans up to 2010 contributed to reduce SHS exposure and its burden 
in children immediately after their implementation, however SHS exposure still occurs and, in 






Exposure to second-hand smoke (SHS) is a major cause of disease among children, and there 
is no safe level of SHS exposure (1-2). It has been shown to be associated with many adverse 
health effects among children, and the diseases with the strongest evidence of a causal link 
with SHS exposure in children are asthma, lower respiratory tract infections (LRI), otitis 
media (OM), and sudden infant death syndrome (SIDS)(2-3). Moreover, exposure to SHS 
during pregnancy are detrimental to fetal growth and development, leading to adverse birth 
outcomes such as preterm birth, low birthweight (LBW), being small for gestational age, and 
perinatal and infant mortality (2-3).    
Children are involuntarily exposed to SHS from their parents smoking at home. However, in 
the last 20 years in many countries worldwide, the implementation of smoking bans in 
workplaces, including the hospitality sector, following Article 8 of the World Health 
Organization (WHO) Framework Convention for Tobacco Control, have had, in the early 
years, an indirect effect of increasing voluntary smoking bans in homes, that may also result 
from increases in cessation rates in household members (4-6). For example, smoke-free 
homes increased from 72% in 2008 to 78% in 2012 in Italy (7-8), from 16% in 1998 to almost 
50% in 2008 in smokers’ houses in England (9), by 50% in Scotland (10), and SHS exposure 
at home declined from 29.2% in 2006 to 12.7% in 2011 in Spain (11). Moreover, the 
introduction of smoke-free legislation in Scotland showed a 39% reduction in salivary 
cotinine concentration among children (12).  
As a consequence of the adoption of smoke-free houses, smoking bans had the further indirect 
effect of reducing the diseases in children due to SHS exposure mainly at home, and in 
newborns, due to SHS exposure among pregnant women in any setting. A recent meta-
analysis that included 41 studies, among which 16 from Europe, showed an association 
between the implementation of smoke-free legislation and reductions in the rates of 
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hospitalization from asthma exacerbations (-9.8%, 95% confidence intervals [CI]: -16.6%,-
3.0%), LRI (-18.5%, 95%CI: -32.8%, -4.2%), and LBW (-2.8%, 95%CI: -4.4%,-1.2%) in 
children (13). In Scotland, smoke-free legislation was associated with a gradual decrease in 
acute LRI events (14), and in the rate of asthma admissions in children (15). In Hungary, the 
strengthening of smoking bans improved the probability of live births (16), and the 
introduction of national smoke-free legislation in England was associated with fewer hospital 
admissions per year for respiratory tract infection and asthma in children (17-18). 
Despite the increase of smoke-free homes in the early years after smoking legislation with 
subsequent increase in children’s health, many children and pregnant women are still exposed 
to SHS in European Union (EU) countries in recent years. As an example, in 2010 in Italy, 
54% of youths were exposed to SHS in any setting (19), and in 2016, 72% of children under 
12 years were exposed in any setting in Spain (20). Moreover, in a Spanish birth cohort, 30% 
pregnant women were exposed to SHS during 1997 to 2008 (21), in Poland the prevalence in 
pregnant women was estimated as 13% in 2008 (22), and, recently, in a sample of Slovak 
pregnant women 28% of them lived with a smoking partner (23).  
As a consequence, the burden of disease due to SHS exposure in children should be still 
considerable.  
A full understanding of the exposure to SHS at home in children and the consequent burden 
of diseases for the whole EU population of children and newborns in the last decade is 
lacking. The aim of this study, conducted within the TackSHS project (24), is to quantify the 
burden of disease due to SHS exposure at home among children and to SHS exposure in 
pregnancy in the last 10 years in 28 EU countries. 
 
Methods 
Burden of disease from second-hand exposure 
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The burden of disease from exposure to SHS in children was estimated for each country using 
the comparative risk assessment methodology (25). In brief, we selected the diseases for 
which there is evidence of a causal relationship with SHS exposure and for which there is 
sufficient quantitative information (25). Then for each SHS-related disease (LBW, SIDS, 
LRI, OM and asthma exacerbation) the country-specific mortality and morbidity attributable 
to exposure to SHS was calculated by first estimating the SHS attributable fraction (AFSHS) 
for each age-group using the Levin’s formula (26) 
 
where p is the prevalence of exposure to SHS (by age groups in each country) and RR is the 
corresponding relative risk of death or disease from the SHS-related disease for exposed to 
SHS compared to not exposed.  
For each disease and country, the population AFSHS (PAF) was then obtained as a weighted 
sum of age-specific AFSHS with the proportion of cases in each stratum as weight. The PAF 
represents the reduction in the population burden of disease that would occur if exposure to 
SHS was removed. The age-groups included in the analysis varied depending on the disease 
under study. The number of deaths attributable to SHS exposure was obtained by multiplying 
the age-specific number of deaths for the corresponding AFSHS and summing over ages. The 
number of disability-adjusted life years (DALYs) was similarly computed.  
For each estimate of deaths and DALYs attributable to SHS exposure, an uncertainty interval 
(UI) was obtained with a Monte Carlo procedure which deal simultaneously with uncertainty 
arising from estimates of SHS exposure, RR and deaths or DALYs (25) (see Supplementary 
material). 
 
Exposure to second-hand smoke 
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We used data from the Eurobarometer surveys carried out in 2006, 2010, 2014 and 2017, that 
are regular face-to-face interviews with approximately 1,000 subjects in each EU country (see 
Supplementary Material). We excluded the 2008 and 2012 surveys in order to contain the 
amount of data (and missing data) and to maintain a 3-4 year interval between surveys. Since 
SHS exposure was not uniformly asked in all surveys we used a multiple imputation 
procedure to estimate SHS exposure at home for the missing years (see Supplementary 
Material) (27).  
In detail, we created a new data set including socio-demographic, smoking and SHS exposure 
variables from all the surveys (28), and we replaced each missing value with a plausible one 
M times (creating M complete datasets), choosing M according to the rule of thumb based on 
the average percentage rate of missingness (29). This step was carried out with the 
Multivariate Imputation by Chained Equations procedure which involves specifying a 
posterior distribution for all incomplete variables and required a preliminary step consisting in 
the selection of a set of predictors to be included in the regressions (27,30). The predictors 
included socio-demographic individual variables, such as gender, age, marital status, and 
survey’s specific variables, such as country, year and survey weight. The regressions used 
varied according to the nature of the variables (logistic or polytomous logistic regressions and 
proportional odds models). Each of the M complete datasets was then analyzed with standard 
statistical methods and the results were then pooled to obtain a final point estimate and a 
measure of precision which accounts for uncertainty due to missing information (27). Our 
data presented two different patterns of missing values. The first one is systematically missing 
data, which are those variables completely missing in some surveys. The second type of 
missing values, i.e. sporadically missing data, is partly and randomly missing in some 
surveys. We took into account for the clustered structure of the data coming from different 
surveys by forcing the survey year to be a predictor (28,31). 
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The final SHS exposure for children used in the burden estimation represents the proportion 
of people with children that allow smoking in their house and were specific for age groups 0-9 
and 10-14 years. Exposure among pregnant women was defined as the proportion of women 
aged 25-44 years being ever exposed to SHS in any setting (house, workplace, car or public 
places). The age class 25-44 was chosen in order to take into account for the average age of 
women at childbirth in EU countries, that, in 2017, varied between 26 years of age in Bulgaria 
and 31 years of age in Italy, with an average of 29 years in EU (32). Both SHS exposure 
measures were estimated taking into account for the survey weights ensuring that each 
country is represented in proportion to its population size and to its sample composition (see 
Supplementary material).  
 
Data  
The RRs of death or incidence from LBW, SIDS, LRI, OM and asthma exacerbation for 
exposed to SHS in comparison to not exposed were estimated from the most recent meta-
analyses. In table 1 the selected RRs values, with the referring age-groups, SHS exposure 
definition and references are reported. 
 
Table 1 here 
 
For years 2006, 2010 and 2014, the age-specific number of deaths from each disease for each 
country were extracted from the Eurostat (http://ec.europa.eu/eurostat/data/database/) and 
WHO (http://data.euro.who.int/dmdb/) databases that report observed data from EU Members 
States' National Statistical Institutes. For year 2017 death were extracted from the Global 
Health Data Exchange of the Global Burden of Disease (GBD) study, an international project 
that annually quantifies and globally compares the health loss due to diseases, accidents and 
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risk factors by age, sex and geographical area and is compliant with the Guidelines for 
Accurate and Transparent Health Estimates Reporting (39-40). 
For years 2006, 2010 and 2014 the country- and age-specific DALY from each disease were 
computed by first estimating the years of life lost (by applying the life expectancy extracted 
from Eurostat to the number of deaths collected from the Eurostat/WHO databases) and then 
summing them to the years lived with disability estimated within the GBD study. For 2017 the 
DALY estimates of GBD were used. 
In Supplemental Table S4 of the Supplementary Material the list of ICD X codes used to 
select the diseases from the WHO/Eurostat databases and from the GBD study are presented. 
While the same classification was used to identify deaths and DALYs from SIDS and asthma 
from WHO/Eurostat and GBD, some differences were observed in the codes for LBW, LRI 
and OM (see Supplementary Material).  
 
Results 
The multiple imputation procedure was run with M=80 imputations. Exposure to SHS at 
home in the overall EU among children stalled from 2006 to 2017 with values of 10.1% in 
2006 (95% confidence interval [CI]: 4.1%-16.1%), 9.6% (95%CI: 1.8%-17.9%) in 2010, 
10.8% (95%CI: 1.9%-20.2%) in 2014, and 12.1% (95%CI: 3.3%-21.4%) in 2017. Exposure to 
SHS for pregnant women in the overall EU stalled from 2006 to 2017 with values of 19.8% in 
2006 (95% CI: 12.6%-27.1%), 19.1% (95%CI: 8.8%-29.4%) in 2010, 20.4% (95%CI: 9.2%-
31.7%) in 2014, and 21.0% (95%CI: 8.7%-33.4%) in 2017. Prevalence estimates were largely 
uncertain due to the large amount of missing data taken into account in the multiple 
imputation procedure, and by visual inspection of confidence intervals, we can conclude that 
differences in prevalence were not significant. 
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As a consequence of the trend in SHS prevalence, the SHS-PAF in the EU countries were 
stables for all the diseases (table 2). 
 
Table 2 here 
 
In 2017 the number of deaths and DALYs attributable to SHS exposure were respectively 335 
(UI: 88-772) and 35,633 (UI: 11,141-78,176). The proportion of deaths and DALYs 
attributable to SHS exposure on the total number of deaths and DALYs among children in the 
EU was respectively 1.4% and 0.7%. The proportion of DALYs varied between values higher 
than 1.5% in Malta, Slovakia, Bulgaria, Poland and Romania, and values lower than 0.4% in 
Finland, The Netherlands, Begium and Luxemburg (Figure 1). 
In 2017 LBW caused most part of both deaths and years of healthy life lost due to prenatal 
SHS exposure, with a proportion of DALYs of 0.4% in all the EU countries, reaching a 
maximum of 1.1% in Poland. Low birth weight was followed by LRI, asthma, SIDS and 
finally by OM with around 0.1% DALYs attributable to SHS on the overall DALYs (Figure 
2). In Eastern EU countries such as Poland, Bulgaria, Slovakia, and also Malta, DALYs due 
to SHS exposure were mainly from LBW with a proportion up to 1.1% in Poland, whereas in 
Romania and Bulgaria a high proportion of SHS-related DALYs was from LRI (Figure 2). 
 
Discussion 
This study provides evidence indicating a stall in SHS household exposure in children and in 
SHS exposure among pregnant women in all settings, and, consequently, in PAFs estimates.  
In the first period, from 2006 to 2010, slightly lower values of SHS exposure in children and 
pregnant women were estimated and this may be in part due to the implementation of 
smoking bans in 16 out of 28 EU countries (Luxembourg, Belgium, the UK, Spain, Finland, 
 
 13 
Slovenia, Lithuania, Denmark, France, Portugal, Croatia, Slovakia, Latvia, Cyprus, Greece, 
Germany). Other 6 EU countries implemented nation-wide smoking bans maximum two years 
before 2006, i.e. in 2004-2005 (Ireland, Sweden, Malta, Italy, Estonia, The Netherlands), 
whereas, after 2010, only 6 EU countries developed smoking bans (Poland, Hungary, 
Bulgaria, Romania, Czechia, Austria). The stall in SHS prevalence estimates from 2010 to 
2017 suggests that comprehensive smoking bans had less influence in the adoption of smoke 
free homes in the long run. In this period, other tobacco control measures were implemented 
in EU countries with no significant impact on SHS exposure at home. Specifically, in the 
whole period tax increases and anti-tobacco mass-media campaigns were implemented in 
some countries; pictorial warnings in tobacco packages was implemented in all EU countries 
in 2016 and smoking bans in cars with children or pregnant women was applied in some 
countries in 2015-2017, e.g., in UK, France, Italy. Thus, smoking bans could have an 
immediate effect in slightly reducing smoking at home, but, SHS exposure still occurs and its 
burden is substantial in the long run. 
A recent systematic review showed findings from 26 studies evaluating the burden of disease 
due to SHS exposure in children for different countries worldwide, with PAF estimates that 
largely varied among studies. PAF estimates, mainly associated to incidence, except for SIDS, 
ranged between 0.9% and 22.4% for OM, 6.7%-43.6% for SIDS, 2.0%-31.9% for LRI, 0.8%-
35% for asthma and 2.1%-23.5% for LBW (3), since they are dependent on the prevalence of 
exposure to SHS, which largely varies across countries (25). The PAFs estimated in this study 
are in line with the lower ranges of those estimated in the systematic review, whereas a recent 
study estimated PAF attributable to SHS exposure from for OM, asthma and LRI for 2015 in 
Spain slightly lower in comparison to our estimates, probably due to higher a estimate of SHS 
exposure, defined by the existence of at least one smoker among household members (41). 
 
 14 
In 2017 the GBD study, that provides a comprehensive assessment of risk factor exposure and 
attributable burden of disease, estimated, for the EU countries, a total of 186 deaths and 
20870 DALYs attributable to SHS exposure in children younger than 14 years of age, 
substantially less than our estimate of 335 deaths and 35633 DALYs (39). This is likely due 
to the exclusion of LBW, SIDS and asthma from the burden quantification of GBD estimates, 
and we showed that LBW was one of the diseases that mainly contributed to the burden from 
SHS exposure in children, especially in Eastern EU countries, determined from SHS exposure 
in pregnancy. 
Our results show that in 2017 the burden was lower in Northern European countries, such as 
Luxembourg, Belgium, The Netherlands, Finland, Estonia and Sweden, and higher in Eastern 
countries, such as Romania, Poland, Bulgaria and Slovakia. Part of the countries with a lower 
SHS burden are those that implemented a smoking ban earlier.  Thus, the distribution of the 
burden due to SHS exposure by disease is not uniform in EU countries. Among those 
countries with a larger burden, Romania and Bulgaria showed a high proportion of DALYs 
attributable to SHS exposure from LRI, whereas Poland, Slovakia, Malta and Bulgaria 
showed a high proportion in DALYs from LBW reaching a proportion of DALYs attributable 
to prenatal SHS exposure on total DALYs of 1.1% in Poland. Low birth weight resulted the 
diseases with the highest proportion of both deaths and years of healthy life lost due to SHS 
exposure, suggesting a notable problem of SHS exposure in pregnancy, especially in Eastern 
EU countries.  
There are several surveys that investigated SHS exposure in the EU countries, but SHS 
exposure in public places was the main studied outcome because of the evaluation of smoking 
bans (i.e. Global Tobacco Surveillance System and Eurobarometer surveys), whereas SHS 
household exposure, that is the main source of exposure in children, was not recently 
evaluated. The main strength of this study is that it provides a quantification of the burden due 
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to SHS exposure at home among children in the last 10 years for the 28 EU countries, even if 
the estimates were largely uncertain due to the large amount of missing values taken into 
account in the imputation procedure. Moreover, few studies quantified the burden form SHS 
exposure in pregnancy in EU or in high income countries (42), and, to our knowledge, this is 
the first study which provides a quantification of this burden estimating deaths and DALYs 
from LBW. Another strength is in the data sources: first, Eurobarometer surveys allow 
estimating household SHS exposure with uniform data for all the EU countries; second, 
mortality data for 2006, 2010, and 2014 are observed and not estimated data, and are available 
for all the diseases of interest, reducing the uncertainty that could arise from death estimates. 
The DALYs estimates combine an observed (years of life lost) with an estimated (years lived 
with disability) part, reducing the uncertainty that could arise form an estimation of the total 
DALYs. Moreover, another strength of this study is to use a direct question for SHS home 
exposure estimates, whereas, within the GBD study, household SHS prevalence was 
indirectly estimated using data on household composition and smoking habits (39).  
This study has however some limitations. A first limitation is that, given the exposure 
definition, changes in prevalence refer to changes in the proportion of people with children 
who adopt smoking rules in home, and proportion of women in fertile age being ever 
exposed, independently from the amount (hours) of exposure, that cannot be quantified using 
our data without generating further excessive uncertainty. A more precise estimation of SHS 
exposure taking into account for the effective quantification of exposure could improve 
results, but this information is not available for all the EU countries. 
 A second limitation comes from the age classes of SHS exposure that are not always aligned 
to those of the diseases under study. For example, SIDS refer to children younger than 1 year, 
and the burden was studied with the SHS exposure estimated for children of age 0-9 years. 
We can however reasonably assume that rules on smoke-free houses do not vary with the 
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children age. Another limitation is that the quality of the meta-analysis used to select RR was 
not assessed, but these were chosen only on the basis of being most recent, even if some of 
them included old studies. A final limitation arises from the imputation procedure used to 
estimate SHS exposure that was used to impute data from several sample surveys by imputing 
the data in the combined data matrix from all surveys. This approach assumes that the 
relationship between SHS exposure and its explicative variables found in 2006 and 2010, 
remains unchanged also for years 2014 and 2017. Moreover, our imputation approach does 
not account for differences between the surveys, for example if they are conducted at different 
times or if different sampling methodologies or if are carried out by different organizations. A 
more appropriate approach is to carry out a hierarchical multiple imputation taking into 
account for the multilevel structure of the data given by four independent surveys (28,31,43). 
Hierarchical multiple imputation procedures have already been developed in the literature 
however only take into account for multilevel continuous and binary data, and could not apply 
to the factor variables of our data. However, literature results show that valid inferences form 
hierarchal multiple imputation methods can only be obtained if the dataset gathers a large 
number of clusters and in our study we are working with only four clusters (28,43). Moreover, 
the main feature of the multilevel modeling are to take into account for differences between 
surveys and to include covariates at survey level. In our analysis however, the pooled surveys 
were carried out by the same organization using the same sampling design, and the only 
survey level variable available was the year in which it was carried out that was included 
among the predictors in our imputation model (28).  
In conclusion, in the last decade, despite smoke-free homes initially increased, presumably as 
a result of the implementation of smoking bans (44), our results show that, in the long run, the 
diseases caused by SHS exposure in children are still not negligible. This suggests that 
household SHS exposure in children and among pregnant women are still high.  Up to 1.6% 
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of total DALYs could be avoided eliminating  SHS exposure in children and pregnancy  . 
Preventing exposure of children to SHS in home and prenatal exposure to maternal SHS 
exposure in the EU therefore still requires great and for sure coordinated efforts. 
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Figure 1 – Rank of the proportion of disability-adjusted life years (DALYs) attributable to 
second-hand smoke on total DALYs among children in 2017 in the European Union. AT: 
Austria, BE: Belgium, BG: Bulgaria, CY: Cyprus, CZ: Czech Republic, HR: Croatia, DK: 
Denmark, EE: Estonia, FI: Finland, FR: France, DE: Germany, GR: Greece, HU: Hungary, 
IE: Ireland, IT: Italy, LV: Latvia, LT: Lithuania, LU: Luxembourg, MT: Malta, NL: 
Netherlands, PL: Poland, PT: Portugal, RO: Romania, SK: Slovakia, SI: Slovenia, ES: Spain, 
SE: Sweden, UK: United Kingdom. 
Figure 2 - Proportion of DALYs attributable to SHS on total DALYs by cause and Country, 
2017. 
 
  
 
